Endologix (ELGX) Announces FDA Request for Follow-up Data on EVAS-FORWARD IDE Study of Nellix EVAS System
Tweet Send to a Friend
Endologix, Inc. (Nasdaq: ELGX) announced that the U.S Food and Drug Administration (FDA) has requested the Company provide 2-year patient ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
